Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2059 of 5804
-
Cord blood stem cells aim to tame transplant complication
Disease control CompletedThis study evaluates the safety and effectiveness of two different doses of umbilical cord derived, ex-vivo cultured and expanded Wharton's jelly mesenchymal stem cells (MSCTC-0010) in the treatment of acute Graft versus Host Disease (aGVHD). The first 5 participants enrolled in …
Phase: PHASE1 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
BESPONSA safety tracked in over 400 leukemia patients
Disease control CompletedThe purpose of this study is to learn about the safety and effectiveness of BESPONSA. BESPONSA is approved for treatment of relapsed or refractory CD22-positive acute lymphocytic leukemia. Registration criteria for this study is all patients who starting BESPONSA in Japan from i…
Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Stroke treatment showdown: sedation or anesthesia?
Disease control CompletedObjectives: This study aims to estimate overall treatment benefit (improvement in disability) among acute ischemic stroke patients that are randomized to General Anesthesia (GA) compared with Sedation (CS) during endovascular therapy. Assess safety (as measured by incidence of s…
Phase: PHASE4 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
No-Radiation scoliosis screening could spare thousands of girls from unnecessary x-rays
Diagnosis CompletedIn the scoliosis screening program of the Student Health Service (SHS), Department of Health (DH), in Hong Kong, more than 50% of screened school children prescribed with x-ray examination basing on the screening protocol did not have Cobb angle greater than the referral threshol…
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 12:01 UTC
-
Biosimilar cancer drug CDP1 aims to match cetuximab in advanced tumors
Disease control CompletedColorectal cancer (CRC) is one of the most common human malignant tumors. The incidence and mortality of colorectal cancer in our country are on the rise. Surgery-based, combined with chemotherapy, radiotherapy comprehensive treatment, is the main treatment of colorectal cancer. …
Phase: PHASE1 • Sponsor: Dragonboat Biopharmaceutical Company Limited • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New drug combo shows promise for lung cancer brain metastases
Disease control OngoingThis phase II trial studies how well osimertinib with or without bevacizumab works in treating patients with EGFR positive non-small cell lung cancer that has spread to the brain (brain metastases). Osimertinib may stop the growth of tumor cells by blocking some of the enzymes ne…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New pill aims to keep Crohn's disease in check
Disease control TerminatedThis is a study to demonstrate the effect of oral ozanimod as maintenance therapy in participants with moderately to severely active Crohn's Disease.
Phase: PHASE3 • Sponsor: Celgene • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Phone apps aim to get women moving in underserved neighborhoods
Disease control Recruiting nowBackground: Heart disease is a leading cause of death. People can reduce their heart disease risk by exercising more. Mobile health technology may make people more successful at increasing their exercise. This includes things like physical activity monitors and smartphone apps. …
Phase: NA • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New pill shows promise against advanced cancers in early trial
Disease control CompletedThis study is open to adults with different types of advanced cancer (solid tumors). The purpose of this study is to find out the most suitable dose of BI 907828 (brigimadlin) the participants can tolerate. The most suitable dose is used in the second part to find out whether bri…
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New drug targets genetic weakness in Hard-to-Treat cancers
Disease control OngoingThis phase II MATCH treatment trial identifies the effects of copanlisib hydrochloride (copanlisib) in patients whose cancer has a genetic change called PIK3CA mutation. Copanlisib may stop the growth of cancer cells by blocking PIK3, a protein needed for cell growth. Researchers…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New procedure aims to help Brain-Injury patients breathe on their own
Disease control CompletedTracheotomy weaning and decannulation are one of the important problems in the neurosurgical care unit. Aside from medical, psychological, sociological, economical and ethics problems, tracheotomy increases the duration of the hospital stay and conditions the secondarily future m…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Radiation may replace drugs for some kidney cancer patients
Disease control TerminatedThis phase II trial studies how well stereotactic body radiation therapy works in treating patients with kidney cancer that has spread to other places in the body (metastatic). Stereotactic body radiation therapy uses special equipment to position a patient and deliver radiation …
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New depression pill shows promise in 1-day mood lift trial
Symptom relief CompletedThe purpose of this study is to evaluate the efficacy at 1 day post initial oral dose of zelquistinel (AGN-241751) compared with placebo in participants with Major Depressive Disorder (MDD).
Phase: PHASE2 • Sponsor: Syndeio Biosciences, Inc • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Prostate cancer patients may ditch painful hormone shots, study hints
Disease control CompletedThe goal of this study is to find out if patients with prostate cancer being treated with the medications abiraterone and prednisone can discontinue hormone injections (examples include leuprolide, goserelin, triptorelin and degarelix). Abiraterone and prednisone are pills used t…
Phase: PHASE2 • Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Brain scans could help predict who wakes from coma
Knowledge-focused CompletedRationale: 30-70% of comatose patients admitted to the intensive care unit (ICU) after cardiac arrest never regain consciousness as a result of post anoxic encephalopathy (PAE). Early identification of patients without potential for recovery of brain functioning may prevent inapp…
Sponsor: Rijnstate Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Could fewer shots protect just as well? new study tests hepatitis b vaccine schedules for babies
⭐️ VACCINE ⭐️ CompletedThe main objective of this study is to compare the immunogenicity of the hepatitis B component in children vaccinated with (I) two doses of Infanrix-hexa administered at 2 and 12 months of age versus (II) one dose of Infanrix-hexa and one dose of Twinrix administered respectively…
Phase: PHASE4 • Sponsor: Laval University • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:13 UTC
-
New study tracks how a common heart valve performs in people born with a bicuspid valve
Knowledge-focused CompletedProspective non interventional, observational registry of 150 patients undergoing TAVI with Evolut platform for bicuspid aortic stenosis.
Sponsor: Clinique Pasteur • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
London's low emission zone linked to healthier lungs in children
Knowledge-focused CompletedInvestigating the impact of London's Ultra Low Emission Zone on children's respiratory health
Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New program aims to cut risky pill overload in seniors
Disease control CompletedIn an aging population, most seniors suffer from multiple chronic conditions. When the number of medications taken is ≥5 (polypharmacy), the burden of taking multiple concurrent medications can do more harm than good. Seniors take an average of 7 regular medications and studies l…
Phase: NA • Sponsor: McMaster University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Gut bacteria may boost cancer immunotherapy: new trial launches
Knowledge-focused Recruiting nowThis is an open label, single-center, non-randomized clinical trial on utilization of microbiome as biomarkers and therapeutics in immuno-oncology. This research consists of two parts: part 1: development of microbiome biomarkers for immuno-oncology part 2: proof-of-concept tri…
Phase: NA • Sponsor: Asan Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC